GLP-1 Medications and Breastfeeding: Is It Safe?
There is limited data, and the cautious, honest answer is to wait. Here is why.
The short answer
GLP-1 medications are generally not recommended while breastfeeding, because there is limited safety data and manufacturers advise against use during nursing. The cautious, honest position is to wait until you are no longer breastfeeding, and to make this decision with your physician.
Why the caution
It is not known with confidence how much, if any, of these medications passes into breast milk or how it might affect an infant, and rapid weight loss during nursing has its own considerations. With limited data on a vulnerable population, responsible clinicians default to caution rather than assuming safety.
Ready to start?
$199 Skeptics' Trial, see if it works for you
One-time $199 trial with physician evaluation and, only if a prescription is approved and the dispensing pharmacy can fulfill it for the patient's location, one month of compounded semaglutide; the pharmacy confirms packaging and shipping details before fulfillment. No long-term commitment. Standard care starts with a $119 physician review; medication is separate, and compounded semaglutide programs start at $166/month.
Start the 30-day trialWhat to do instead for now
During breastfeeding, the focus is usually on nutrition, gentle activity, sleep where possible, and support, with medication revisited afterward. If you became pregnant or started nursing while on a GLP-1, tell your physician promptly so they can guide next steps. Do not start, stop, or adjust on your own.
How this relates to what we offer
Our $119 review screens for pregnancy and breastfeeding, and we do not start GLP-1 treatment during nursing. We will revisit a plan when it is appropriate and safe.
What you can start today at New Hope Weight Loss
After a one-time $119 medical review with Dr. Sharma, eligible patients begin physician-supervised compounded semaglutide from $166 a month or compounded tirzepatide from $233 a month, with a $199 one-month Skeptics' Trial. Compounded semaglutide and tirzepatide are not FDA-approved or brand-identical and have not undergone FDA premarket review for safety, effectiveness, or quality. Results vary. Any prescription depends on individualized medical review and lawful pharmacy fulfillment for the patient's location. In person in Orange County and by telehealth for eligible patients in California.
Frequently asked questions
Can I take semaglutide while breastfeeding?
It is generally not recommended. There is limited safety data and manufacturers advise against GLP-1 use while nursing. The cautious approach is to wait and decide with your physician.
Does semaglutide pass into breast milk?
It is not known with confidence, which is part of why caution is advised. With limited data on infants, responsible clinicians default to not using it during breastfeeding.
I started a GLP-1 and then began breastfeeding. What now?
Tell your physician promptly. Do not adjust on your own; they will guide whether and how to pause and what to do next.
When can I restart after breastfeeding?
Once you are no longer nursing, your physician can reassess and restart a plan if appropriate. Timing is individualized to you.
Does New Hope screen for breastfeeding?
Yes. The $119 review screens for pregnancy and breastfeeding, and we do not start GLP-1 treatment while you are nursing.
This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.